Free radical species and oxidative stress mediator

Free radical species and oxidative stress mediators refer to a collection of molecular entities, primarily reactive oxygen species (ROS) such as superoxide anion (O₂•⁻), hydroxyl radical (•OH), hydrogen peroxide (H₂O₂), and reactive nitrogen species (RNS) like nitric oxide (NO•) and peroxynitrite (ONOO⁻), generated as by-products of normal cellular metabolism through mitochondrial respiration, enzymatic reactions (e.g., NADPH oxidase, xanthine oxidase), and external exposures (e.g., pollutants, drugs, radiation). These species are highly reactive due to unpaired electrons, capable of oxidizing proteins, lipids, and nucleic acids, which may contribute to cellular and tissue damage when present in excess—a state known as oxidative stress. While physiological levels of free radicals play essential roles in cell signaling, redox regulation, and immune responses, excess production leads to oxidative damage implicated in the pathogenesis of diverse conditions such as cardiovascular diseases, neurodegenerative disorders, cancer, and aging. The body maintains redox homeostasis through enzymatic antioxidants (SOD, catalase, glutathione peroxidase) and non-enzymatic defenses (glutathione, vitamins C and E). Therapies targeting free radical species and oxidative stress include antioxidants and enzyme modulators, but clinical translation is challenged by the complex dual role of these species in both normal physiology and pathology[1][3][5][7]. Note: "Free radical species/oxidative stress mediators" is not a canonical therapeutic target but a functional category representing a diverse group of molecular species and mechanisms. For structured drug development or biomarker discovery, focus on specific molecules (e.g., superoxide dismutase, NADPH oxidase) or explicit pathways would be warranted[1][3][5].

Other names

Free radicalsReactive oxygen species (ROS)Reactive nitrogen species (RNS)Oxidative stress mediators

Scavenging free radicals; Inhibition of ROS-generating enzymes (e.g., NADPH oxidase inhibitors, xanthine oxidase inhibitors); Enhancement of endogenous antioxidant enzymes (e.g., SOD mimetics, catalase activators); Modulation of redox-sensitive signaling pathways